• Home
  • >
  • Bharat Parenterals Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/bharat-parenterals-ltd.png Logo

Bharat Parenterals Ltd Financial Statement

Bharat Parenterals Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue61.263.2772.77
Operating Expense52.0253.3858.42
Net Profit5.075.568.89
Net Profit Margin8.288.7912.22
Earning Per Share8.659.6215.4
EBIDTA9.579.4214.49
Effective Tax Rate24.1816.5822.37

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Bharat Parenterals Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2022Mar 2021Mar 2020
Total Revenue Annual212.01204.64228.18
Operating Expenses Annual184.36179.77200.11
Operating Profit Annual35.4333.5539.54
Interest Annual0.890.390.86
Depreciation6.666.035.88
Net Profit Annual21.0520.3924.14
Tax Annual7.066.818.65

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Bharat Parenterals Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2022Mar 2021Mar 2020
Cash Flow at the Beginning1.6810.111.07
Cash Flow from Operations-1.0724.4514.45
Cash Flow from Investing-6.63-43.37-12.6
Cash Flow from Financing9.4210.5-2.82
Cash Flow at the End3.41.6810.1

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Bharat Parenterals Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2022Mar 2021Mar 2020
PBDIT Margin (%)16.9116.5817.33
PBIT Margin (%)13.7713.6314.75
PBT Margin (%)4.53-4.16-2.54
Net PROFIT Margin (%)8.849.9211.62
Return On Networth / Equity (%)13.4415.5122.75
Return On Networth /Employed(%)17.120.1630.74
Return On Assets (%)10.8714.6924.17
Total Debt / Equity(X)0.090.050.03
Asset Turnover Ratio (%)1.231.482.08

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Bharat Parenterals Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2022Mar 2021Mar 2020
Fixed Assets Annual39.7543.3631.75
Total Current Assets Annual143.74148.02131.62
Non Current Assets Annual82.3250.6355.88
Total Shareholders Funds Annual165.83143.87118.19
Total Assets Annual226.06198.65187.5

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Bharat Parenterals Ltd Earning Calls
Dec 2023
EPS beaten by -1.53 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Bharat Parenterals Ltd has a market capitalization of 194.03 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Bharat Parenterals Ltd is debt-free with a debt-to-equity ratio of 0.27.

In FY 2023, Bharat Parenterals Ltd recorded a total revenue of approximately 217.98 Cr marking a significant milestone in the company's financial performance.

Bharat Parenterals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.0% annually, respectively..

Bharat Parenterals Ltd's current PE ratio is 11.80.

Bharat Parenterals Ltd's ROCE averaged 14.8% from the FY ending March 2021 to 2023, with a median of 15.7%. It peaked at 17.6% in March 2021, reflecting strong capital efficiency over the period..

Bharat Parenterals Ltd's latest EBIT is Rs. 25.73 Cr, surpassing the average EBIT of Rs. 27.36 Cr over the 5 years..